Quebec Denies $27,000 Monthly Brain Cancer Treatment, Patient Feels Abandoned
A young man diagnosed with aggressive brain cancer has expressed his dismay over Quebec’s refusal to cover a $27,000 monthly treatment that could extend his life by several years. Samuel Rochon, who has been battling a grade 4 glioblastoma, feels insulted and abandoned by the system. “To think that in 2026, a viable treatment is denied feels like my life is being assigned a monetary value,” he shared.
Critical Treatment Denied
On January 1, 2025, Rochon faced a recurrence of his cancer, prompting another operation and extensive treatments. He has faced numerous adversities in his battle against cancer, including undergoing significant surgeries and 25 rounds of radiation and chemotherapy since his symptoms first appeared in 2016.
- Patient Name: Samuel Rochon
- Condition: Grade 4 glioblastoma (aggressive brain cancer)
- Monthly Treatment Cost: $27,000
- Funding Goal via GoFundMe: $300,000
- Years Survived Post-Diagnosis: Over 8 years
Efforts to Fund Treatment
Rochon launched a crowdfunding campaign to cover his treatment, reaching one-third of his $300,000 goal shortly after its inception. He aims not only to secure his treatment but also to raise awareness for others in similar situations who might not have the same opportunities.
Optune: A Promising Yet Unapproved Treatment
The Optune device has been identified as a potential lifeline. Even though it has been evaluated and shown to be effective, it is not recognized for reimbursement by the National Institute of Excellence in Health and Social Services (INESSS). This means the treatment is not funded by Quebec’s health insurance program (RAMQ).
Dr. Sarah Lapointe, Rochon’s oncologist, advocates for the treatment, stating, “It is not experimental; it is an approved and effective treatment.” Despite INESSS recognizing the innovative aspects of the device, uncertainties persist regarding its implementation in Quebec’s healthcare system.
A Life Beyond Limits
Rochon, who lost his left leg to a congenital condition at age six, does not let his health define him. He has embraced life fully, running a half-marathon while undergoing chemotherapy and traveling to 22 countries.
His future aspirations include creating a foundation to support children in his community and becoming a father. Despite the looming challenges of his condition, Rochon, who will turn 32 on February 5, remains resolute in pursuing his dreams.
| Activity | Details |
|---|---|
| Half-Marathon | Completed in 2017 during chemotherapy |
| Travel | Visited 22 countries, including Peru, Tanzania, and Nepal |
Rochon’s story highlights the ongoing struggle for access to life-saving treatments and the emotional toll of battling severe health conditions. As he continues his fight, he hopes to inspire others to seek the support and care they deserve.
